About
Develops a microfluidic Gut–Brain organ-on-chip that enables dynamic-flow, high-throughput screening to identify microbiome-mediated neuroactive compounds and probiotic strains for neuropsychiatric and neurodegenerative applications.
Explore Neurobiome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.